Kenya Receives First Doses of Long-Acting Injectable HIV Drug

Kenya has received 21,000 doses of the long-acting HIV prevention injection Lenacapavir, with rollout set to begin in March...

✨ Key Highlights

Kenya has received its initial shipment of 21,000 starter doses of Lenacapavir, an injectable HIV pre-exposure prophylaxis (PrEP).

These doses, received on Tuesday, February 17, through a partnership with the Global Fund, will be rolled out starting March in 15 high-burdened counties.
Health Director General Patrick Amoth confirmed that an additional 12,000 continuation doses are expected by April, with another 25,000 doses from the U.S. Government to follow.
The drug, approved by the U.S. Food and Drug Administration in June 2025 and subsequently by the World Health Organisation (WHO), is administered twice a year at an estimated cost of Ksh 7,800 per patient.

Continue Reading

Read the complete article from Kenyans

📰 Read Full Article

Related News

top11h ago

Kenya receives 21,000 doses of injectable HIV prevention drug

Kenya has received 21,000 starter doses of Lenacapavir, a long-acting injectable HIV prevention drug, positioning it as the first country in East Africa to introduce this innovation. This significant delivery marks a crucial step in the nation's fight against new HIV infections, particularly among its youth.

KBC Top Stories

📰 Read Full Story

Video

Kenya launches long-acting injectable HIV prevention medicine in phased rollout

The Star (Youtube)

17h ago

top8h ago

New HIV prevention injection arrives in Kenya

A new HIV prevention injection, Lenacapavir, has arrived in Kenya, offering a potentially "game-changing" treatment that requires only two injections a year.

Capital News

📰 Read Full Story

entertainment16h ago

HIV vaccine finally available in Kenya

Kenya has officially launched Lenacapavir, a new long-acting injectable medication for HIV prevention, marking a major step in curbing new transmissions. This Pre-Exposure Prophylaxis (PrEP) option offers HIV-negative individuals up to six months of protection per dose, providing a convenient alternative to daily oral pills.

Ghafla! (Entertainment)

📰 Read Full Story